ARTICLE | Company News
biOasis, AstraZeneca deal
November 19, 2012 8:00 AM UTC
biOasis partnered with AstraZeneca's MedImmune LLC biologics unit to evaluate biOasis' Transcend technology in transporting to the brain "compounds of interest" to MedImmune. Transcend is a soluble ...